DexCom
Trade DexCom 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About DXCM
DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G6, Dexcom G7, Dexcom Stelo, Dexcom Share, Dexcom Real-Time API, and Dexcom ONE.
DXCM Key Statistics
Stock Snapshot
With a market cap of 22.64B, DexCom(DXCM) trades at $58.01. The stock has a price-to-earnings ratio of 33.24.
As of 2025-11-14, DexCom(DXCM) stock has fluctuated between $57.50 and $60.19. The current price stands at $58.01, placing the stock +0.9% above today's low and -3.6% off the high.
The DexCom(DXCM)'s current trading volume is 5.38M, compared to an average daily volume of 11.73M.
During the past year, DexCom(DXCM) stock moved between $54.11 at its lowest and $93.25 at its peak.
During the past year, DexCom(DXCM) stock moved between $54.11 at its lowest and $93.25 at its peak.
DXCM News
DexCom, Inc. ( ) shareholders (or potential shareholders) will be happy to see that the Interim CEO, Jacob Leach, recently bought a whopping US$1.0m worth of st...
In November 2025, Carrot announced a partnership with OURA and DexCom to deliver personalized insights and metabolic-fertility support through Carrot’s Sprints...
Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably...
Analyst ratings
84%
of 31 ratingsMore DXCM News
In early trading on Tuesday, shares of DexCom topped the list of the day's best performing components of the Nasdaq 100 index, trading up 2.8%. Year to date, De...
Morgan Stanley lowered the firm’s price target on DexCom (DXCM) to $63 from $89 and keeps an Overweight rating on the shares. Meet Your ETF AI Analyst Discove...